Cancer Molecular Biology program members study the basic science that is behind our ability to develop safer and more effective cancer treatments.
Program members conduct basic and translational research and commonly use molecular, biological, genetic and pharmacologic tools to perform analysis of pathways intrinsic to cancer therapeutics, with emphasis on angiogenesis, receptor-mediated signaling, apoptosis, epigenetics and transcriptional interference.
Dr. Nita Maihle, associate director for basic research, heads the program.
Work progresses through three divisions:
Molecular cancer therapeutics, seeks to develop safer and more effective cancer treatments. The program’s scientific goals include:
Tumor cell biology,seeks to understand the molecular and cellular processes that cause cancer and cancer progression. The program’s scientific goals include: